Testing a new light device for newborn jaundice
Part of Genetic & congenital clinical trials.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born after 35 weeks of pregnancy
- Your baby has jaundice confirmed by a bilirubin test (a skin or blood measurement)
- Your baby’s jaundice level is high enough to need light treatment (phototherapy), based on standard guidelines
- Your baby weighs at least 2.5 kg
- Your baby has no serious signs at birth that make them too unwell (for example, breathing problems or other major complications)
- Your baby has no certain blood-type problems (rhesus or Kell incompatibility)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial compares two medicines, fenofibrate and phenobarbitone, added to standard light therapy to see which works better at lowering bilirubin levels in full-term newborns with jaundice. It aims to find a faster or more effective way to treat jaundice and reduce the need for more intensive treatments.
This study tests a device that measures jaundice (yellowing of the skin) through the skin rather than with a blood test. It may help newborns avoid a needle stick.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
Hear when a new Neonatal Jaundice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.